nodes	percent_of_prediction	percent_of_DWPC	metapath
Vecuronium—ABCB1—Mycophenolate mofetil—psoriasis	0.0655	0.168	CbGbCtD
Vecuronium—ABCB1—Betamethasone—psoriasis	0.0562	0.144	CbGbCtD
Vecuronium—ABCB1—Prednisolone—psoriasis	0.0555	0.142	CbGbCtD
Vecuronium—ABCB1—Hydrocortisone—psoriasis	0.0526	0.135	CbGbCtD
Vecuronium—ABCB1—Prednisone—psoriasis	0.0524	0.134	CbGbCtD
Vecuronium—ABCB1—Cyclosporine—psoriasis	0.0497	0.127	CbGbCtD
Vecuronium—ABCB1—Dexamethasone—psoriasis	0.0327	0.0837	CbGbCtD
Vecuronium—ABCB1—Methotrexate—psoriasis	0.0263	0.0672	CbGbCtD
Vecuronium—Steroid myopathy—Prednisolone—psoriasis	0.024	0.0394	CcSEcCtD
Vecuronium—Steroid myopathy—Hydrocortisone—psoriasis	0.0234	0.0384	CcSEcCtD
Vecuronium—Steroid myopathy—Triamcinolone—psoriasis	0.022	0.0362	CcSEcCtD
Vecuronium—Steroid myopathy—Betamethasone—psoriasis	0.02	0.0328	CcSEcCtD
Vecuronium—Steroid myopathy—Dexamethasone—psoriasis	0.02	0.0328	CcSEcCtD
Vecuronium—Steroid myopathy—Prednisone—psoriasis	0.0174	0.0286	CcSEcCtD
Vecuronium—Drug ineffective—Mycophenolate mofetil—psoriasis	0.0171	0.028	CcSEcCtD
Vecuronium—Redness—Methoxsalen—psoriasis	0.0107	0.0175	CcSEcCtD
Vecuronium—Muscle atrophy—Dexamethasone—psoriasis	0.00978	0.0161	CcSEcCtD
Vecuronium—Muscle atrophy—Betamethasone—psoriasis	0.00978	0.0161	CcSEcCtD
Vecuronium—Redness—Calcitriol—psoriasis	0.0095	0.0156	CcSEcCtD
Vecuronium—Muscle atrophy—Prednisone—psoriasis	0.00852	0.014	CcSEcCtD
Vecuronium—Redness—Acitretin—psoriasis	0.00846	0.0139	CcSEcCtD
Vecuronium—Myopathy—Acitretin—psoriasis	0.00814	0.0134	CcSEcCtD
Vecuronium—Rash erythematous—Acitretin—psoriasis	0.00745	0.0122	CcSEcCtD
Vecuronium—Erythema—Calcipotriol—psoriasis	0.00707	0.0116	CcSEcCtD
Vecuronium—Bronchospasm—Beclomethasone—psoriasis	0.00568	0.00932	CcSEcCtD
Vecuronium—Erythema—Tazarotene—psoriasis	0.00521	0.00856	CcSEcCtD
Vecuronium—Connective tissue disorder—Clobetasol propionate—psoriasis	0.00499	0.00819	CcSEcCtD
Vecuronium—Apnoea—Mycophenolic acid—psoriasis	0.00443	0.00727	CcSEcCtD
Vecuronium—Erythema—Clobetasol propionate—psoriasis	0.00442	0.00726	CcSEcCtD
Vecuronium—Myopathy—Cyclosporine—psoriasis	0.00433	0.00711	CcSEcCtD
Vecuronium—Hypersensitivity—Calcipotriol—psoriasis	0.00425	0.00698	CcSEcCtD
Vecuronium—Myopathy—Mycophenolate mofetil—psoriasis	0.00422	0.00693	CcSEcCtD
Vecuronium—Immune system disorder—Fluocinonide—psoriasis	0.00414	0.00679	CcSEcCtD
Vecuronium—Redness—Hydrocortisone—psoriasis	0.004	0.00656	CcSEcCtD
Vecuronium—Erythema—Fluocinonide—psoriasis	0.00399	0.00654	CcSEcCtD
Vecuronium—Myopathy—Prednisolone—psoriasis	0.00394	0.00647	CcSEcCtD
Vecuronium—Myopathy—Hydrocortisone—psoriasis	0.00385	0.00632	CcSEcCtD
Vecuronium—Respiratory failure—Mycophenolic acid—psoriasis	0.00382	0.00627	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Clobetasol propionate—psoriasis	0.00374	0.00613	CcSEcCtD
Vecuronium—Angioedema—Beclomethasone—psoriasis	0.00368	0.00604	CcSEcCtD
Vecuronium—Muscular weakness—Acitretin—psoriasis	0.00365	0.006	CcSEcCtD
Vecuronium—Rash—Calcipotriol—psoriasis	0.00364	0.00597	CcSEcCtD
Vecuronium—Dermatitis—Calcipotriol—psoriasis	0.00364	0.00597	CcSEcCtD
Vecuronium—Myopathy—Triamcinolone—psoriasis	0.00362	0.00595	CcSEcCtD
Vecuronium—Skin disorder—Clobetasol propionate—psoriasis	0.0035	0.00575	CcSEcCtD
Vecuronium—Apnoea—Mycophenolate mofetil—psoriasis	0.00349	0.00574	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Fluocinonide—psoriasis	0.00337	0.00553	CcSEcCtD
Vecuronium—Myopathy—Betamethasone—psoriasis	0.00329	0.0054	CcSEcCtD
Vecuronium—Myopathy—Dexamethasone—psoriasis	0.00329	0.0054	CcSEcCtD
Vecuronium—Anaphylactic shock—Beclomethasone—psoriasis	0.00328	0.00539	CcSEcCtD
Vecuronium—Nervous system disorder—Fluocinonide—psoriasis	0.00319	0.00524	CcSEcCtD
Vecuronium—Skin disorder—Fluocinonide—psoriasis	0.00316	0.00519	CcSEcCtD
Vecuronium—Erythema—Methoxsalen—psoriasis	0.00315	0.00517	CcSEcCtD
Vecuronium—Face oedema—Hydroxyurea—psoriasis	0.00314	0.00516	CcSEcCtD
Vecuronium—Respiratory failure—Mycophenolate mofetil—psoriasis	0.00302	0.00495	CcSEcCtD
Vecuronium—Rash erythematous—Dexamethasone—psoriasis	0.00301	0.00494	CcSEcCtD
Vecuronium—Rash erythematous—Betamethasone—psoriasis	0.00301	0.00494	CcSEcCtD
Vecuronium—Injection site reaction—Mycophenolate mofetil—psoriasis	0.00294	0.00483	CcSEcCtD
Vecuronium—Myopathy—Prednisone—psoriasis	0.00286	0.0047	CcSEcCtD
Vecuronium—Connective tissue disorder—Fluocinolone Acetonide—psoriasis	0.00281	0.00461	CcSEcCtD
Vecuronium—Erythema—Calcitriol—psoriasis	0.0028	0.0046	CcSEcCtD
Vecuronium—Rash—Tazarotene—psoriasis	0.00268	0.0044	CcSEcCtD
Vecuronium—Dermatitis—Tazarotene—psoriasis	0.00268	0.0044	CcSEcCtD
Vecuronium—Flushing—Acitretin—psoriasis	0.00266	0.00437	CcSEcCtD
Vecuronium—Hypersensitivity—Clobetasol propionate—psoriasis	0.00266	0.00436	CcSEcCtD
Vecuronium—Face oedema—Mycophenolic acid—psoriasis	0.00263	0.00432	CcSEcCtD
Vecuronium—Urticaria—Beclomethasone—psoriasis	0.00261	0.00428	CcSEcCtD
Vecuronium—Angiopathy—Acitretin—psoriasis	0.0026	0.00427	CcSEcCtD
Vecuronium—Immune system disorder—Acitretin—psoriasis	0.00259	0.00425	CcSEcCtD
Vecuronium—Mediastinal disorder—Fluocinolone Acetonide—psoriasis	0.00258	0.00423	CcSEcCtD
Vecuronium—Erythema—Acitretin—psoriasis	0.0025	0.0041	CcSEcCtD
Vecuronium—Skin disorder—Methoxsalen—psoriasis	0.00249	0.0041	CcSEcCtD
Vecuronium—Erythema—Fluocinolone Acetonide—psoriasis	0.00249	0.00408	CcSEcCtD
Vecuronium—Paralysis—Methotrexate—psoriasis	0.00242	0.00396	CcSEcCtD
Vecuronium—Muscular weakness—Mycophenolic acid—psoriasis	0.0024	0.00394	CcSEcCtD
Vecuronium—Hypotension—Methoxsalen—psoriasis	0.0024	0.00394	CcSEcCtD
Vecuronium—Hypersensitivity—Fluocinonide—psoriasis	0.0024	0.00394	CcSEcCtD
Vecuronium—Anaphylactic shock—Calcitriol—psoriasis	0.00229	0.00376	CcSEcCtD
Vecuronium—Angioedema—Acitretin—psoriasis	0.00228	0.00374	CcSEcCtD
Vecuronium—Anaphylactoid reaction—Cyclosporine—psoriasis	0.00228	0.00374	CcSEcCtD
Vecuronium—Rash—Clobetasol propionate—psoriasis	0.00227	0.00373	CcSEcCtD
Vecuronium—Dermatitis—Clobetasol propionate—psoriasis	0.00227	0.00373	CcSEcCtD
Vecuronium—Skin disorder—Calcitriol—psoriasis	0.00222	0.00365	CcSEcCtD
Vecuronium—Face oedema—Mycophenolate mofetil—psoriasis	0.00208	0.00341	CcSEcCtD
Vecuronium—Anaphylactoid reaction—Prednisolone—psoriasis	0.00207	0.0034	CcSEcCtD
Vecuronium—Rash—Beclomethasone—psoriasis	0.00207	0.0034	CcSEcCtD
Vecuronium—Dermatitis—Beclomethasone—psoriasis	0.00207	0.0034	CcSEcCtD
Vecuronium—Rash—Fluocinonide—psoriasis	0.00205	0.00337	CcSEcCtD
Vecuronium—Dermatitis—Fluocinonide—psoriasis	0.00205	0.00336	CcSEcCtD
Vecuronium—Angiopathy—Hydroxyurea—psoriasis	0.00204	0.00335	CcSEcCtD
Vecuronium—Urticaria—Methoxsalen—psoriasis	0.00204	0.00335	CcSEcCtD
Vecuronium—Anaphylactoid reaction—Hydrocortisone—psoriasis	0.00202	0.00332	CcSEcCtD
Vecuronium—Nervous system disorder—Fluocinolone Acetonide—psoriasis	0.00199	0.00327	CcSEcCtD
Vecuronium—Apnoea—Methotrexate—psoriasis	0.00198	0.00325	CcSEcCtD
Vecuronium—Skin disorder—Acitretin—psoriasis	0.00198	0.00325	CcSEcCtD
Vecuronium—Erythema—Hydroxyurea—psoriasis	0.00196	0.00322	CcSEcCtD
Vecuronium—Muscular weakness—Cyclosporine—psoriasis	0.00194	0.00319	CcSEcCtD
Vecuronium—Anaphylactoid reaction—Triamcinolone—psoriasis	0.00191	0.00313	CcSEcCtD
Vecuronium—Muscular weakness—Mycophenolate mofetil—psoriasis	0.0019	0.00311	CcSEcCtD
Vecuronium—Hypersensitivity—Methoxsalen—psoriasis	0.00189	0.00311	CcSEcCtD
Vecuronium—Bronchospasm—Cyclosporine—psoriasis	0.00187	0.00308	CcSEcCtD
Vecuronium—Connective tissue disorder—Mycophenolic acid—psoriasis	0.00185	0.00304	CcSEcCtD
Vecuronium—Urticaria—Calcitriol—psoriasis	0.00182	0.00299	CcSEcCtD
Vecuronium—Muscular weakness—Prednisolone—psoriasis	0.00177	0.0029	CcSEcCtD
Vecuronium—Cardiac disorder—Mycophenolic acid—psoriasis	0.00175	0.00287	CcSEcCtD
Vecuronium—Anaphylactoid reaction—Dexamethasone—psoriasis	0.00173	0.00284	CcSEcCtD
Vecuronium—Anaphylactoid reaction—Betamethasone—psoriasis	0.00173	0.00284	CcSEcCtD
Vecuronium—Muscular weakness—Hydrocortisone—psoriasis	0.00173	0.00284	CcSEcCtD
Vecuronium—Angiopathy—Mycophenolic acid—psoriasis	0.00171	0.00281	CcSEcCtD
Vecuronium—Respiratory failure—Methotrexate—psoriasis	0.00171	0.0028	CcSEcCtD
Vecuronium—Mediastinal disorder—Mycophenolic acid—psoriasis	0.0017	0.00279	CcSEcCtD
Vecuronium—Hypersensitivity—Calcitriol—psoriasis	0.00169	0.00277	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—psoriasis	0.00166	0.00272	CcSEcCtD
Vecuronium—Muscular weakness—Triamcinolone—psoriasis	0.00163	0.00267	CcSEcCtD
Vecuronium—Rash—Methoxsalen—psoriasis	0.00162	0.00266	CcSEcCtD
Vecuronium—Dermatitis—Methoxsalen—psoriasis	0.00162	0.00266	CcSEcCtD
Vecuronium—Urticaria—Acitretin—psoriasis	0.00162	0.00266	CcSEcCtD
Vecuronium—Nervous system disorder—Hydroxyurea—psoriasis	0.00157	0.00257	CcSEcCtD
Vecuronium—Skin disorder—Hydroxyurea—psoriasis	0.00155	0.00255	CcSEcCtD
Vecuronium—Hypersensitivity—Acitretin—psoriasis	0.0015	0.00246	CcSEcCtD
Vecuronium—Connective tissue disorder—Cyclosporine—psoriasis	0.0015	0.00246	CcSEcCtD
Vecuronium—Hypersensitivity—Fluocinolone Acetonide—psoriasis	0.0015	0.00246	CcSEcCtD
Vecuronium—Muscular weakness—Betamethasone—psoriasis	0.00148	0.00242	CcSEcCtD
Vecuronium—Muscular weakness—Dexamethasone—psoriasis	0.00148	0.00242	CcSEcCtD
Vecuronium—Connective tissue disorder—Mycophenolate mofetil—psoriasis	0.00146	0.0024	CcSEcCtD
Vecuronium—Rash—Calcitriol—psoriasis	0.00144	0.00237	CcSEcCtD
Vecuronium—Dermatitis—Calcitriol—psoriasis	0.00144	0.00237	CcSEcCtD
Vecuronium—Flushing—Cyclosporine—psoriasis	0.00142	0.00232	CcSEcCtD
Vecuronium—Face oedema—Prednisone—psoriasis	0.00141	0.00231	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—psoriasis	0.00139	0.00228	CcSEcCtD
Vecuronium—Angiopathy—Cyclosporine—psoriasis	0.00138	0.00227	CcSEcCtD
Vecuronium—Cardiac disorder—Mycophenolate mofetil—psoriasis	0.00138	0.00227	CcSEcCtD
Vecuronium—Mediastinal disorder—Cyclosporine—psoriasis	0.00137	0.00226	CcSEcCtD
Vecuronium—Angiopathy—Mycophenolate mofetil—psoriasis	0.00135	0.00222	CcSEcCtD
Vecuronium—Mediastinal disorder—Mycophenolate mofetil—psoriasis	0.00134	0.0022	CcSEcCtD
Vecuronium—Connective tissue disorder—Hydrocortisone—psoriasis	0.00133	0.00219	CcSEcCtD
Vecuronium—Shock—Mycophenolic acid—psoriasis	0.00132	0.00216	CcSEcCtD
Vecuronium—Nervous system disorder—Mycophenolic acid—psoriasis	0.00131	0.00216	CcSEcCtD
Vecuronium—Tachycardia—Mycophenolic acid—psoriasis	0.00131	0.00215	CcSEcCtD
Vecuronium—Skin disorder—Mycophenolic acid—psoriasis	0.0013	0.00214	CcSEcCtD
Vecuronium—Muscular weakness—Prednisone—psoriasis	0.00129	0.00211	CcSEcCtD
Vecuronium—Rash—Acitretin—psoriasis	0.00128	0.00211	CcSEcCtD
Vecuronium—Dermatitis—Acitretin—psoriasis	0.00128	0.00211	CcSEcCtD
Vecuronium—Rash—Fluocinolone Acetonide—psoriasis	0.00128	0.0021	CcSEcCtD
Vecuronium—Dermatitis—Fluocinolone Acetonide—psoriasis	0.00128	0.0021	CcSEcCtD
Vecuronium—Anaphylactoid reaction—Methotrexate—psoriasis	0.00126	0.00207	CcSEcCtD
Vecuronium—Hypotension—Mycophenolic acid—psoriasis	0.00125	0.00205	CcSEcCtD
Vecuronium—Immune system disorder—Hydrocortisone—psoriasis	0.00122	0.00201	CcSEcCtD
Vecuronium—Angioedema—Cyclosporine—psoriasis	0.00121	0.00199	CcSEcCtD
Vecuronium—Erythema—Prednisolone—psoriasis	0.00121	0.00198	CcSEcCtD
Vecuronium—Angioedema—Mycophenolate mofetil—psoriasis	0.00118	0.00194	CcSEcCtD
Vecuronium—Erythema—Hydrocortisone—psoriasis	0.00118	0.00194	CcSEcCtD
Vecuronium—Hypersensitivity—Hydroxyurea—psoriasis	0.00118	0.00193	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—psoriasis	0.00112	0.00184	CcSEcCtD
Vecuronium—Erythema—Triamcinolone—psoriasis	0.00111	0.00182	CcSEcCtD
Vecuronium—Angioedema—Prednisolone—psoriasis	0.0011	0.00181	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—psoriasis	0.00109	0.0018	CcSEcCtD
Vecuronium—Anaphylactic shock—Cyclosporine—psoriasis	0.00108	0.00178	CcSEcCtD
Vecuronium—Angioedema—Hydrocortisone—psoriasis	0.00108	0.00177	CcSEcCtD
Vecuronium—Nervous system disorder—Cyclosporine—psoriasis	0.00106	0.00174	CcSEcCtD
Vecuronium—Anaphylactic shock—Mycophenolate mofetil—psoriasis	0.00106	0.00173	CcSEcCtD
Vecuronium—Skin disorder—Cyclosporine—psoriasis	0.00105	0.00173	CcSEcCtD
Vecuronium—Angiopathy—Dexamethasone—psoriasis	0.00105	0.00172	CcSEcCtD
Vecuronium—Angiopathy—Betamethasone—psoriasis	0.00105	0.00172	CcSEcCtD
Vecuronium—Shock—Mycophenolate mofetil—psoriasis	0.00104	0.00171	CcSEcCtD
Vecuronium—Nervous system disorder—Mycophenolate mofetil—psoriasis	0.00104	0.0017	CcSEcCtD
Vecuronium—Tachycardia—Mycophenolate mofetil—psoriasis	0.00103	0.00169	CcSEcCtD
Vecuronium—Skin disorder—Mycophenolate mofetil—psoriasis	0.00103	0.00169	CcSEcCtD
Vecuronium—Angioedema—Triamcinolone—psoriasis	0.00102	0.00167	CcSEcCtD
Vecuronium—Rash—Hydroxyurea—psoriasis	0.00101	0.00165	CcSEcCtD
Vecuronium—Erythema—Dexamethasone—psoriasis	0.00101	0.00165	CcSEcCtD
Vecuronium—Erythema—Betamethasone—psoriasis	0.00101	0.00165	CcSEcCtD
Vecuronium—Dermatitis—Hydroxyurea—psoriasis	0.00101	0.00165	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—psoriasis	0.000997	0.00164	CcSEcCtD
Vecuronium—Connective tissue disorder—Prednisone—psoriasis	0.000991	0.00163	CcSEcCtD
Vecuronium—Hypotension—Mycophenolate mofetil—psoriasis	0.000988	0.00162	CcSEcCtD
Vecuronium—Anaphylactic shock—Prednisolone—psoriasis	0.000986	0.00162	CcSEcCtD
Vecuronium—Shock—Prednisolone—psoriasis	0.00097	0.00159	CcSEcCtD
Vecuronium—Anaphylactic shock—Hydrocortisone—psoriasis	0.000963	0.00158	CcSEcCtD
Vecuronium—Tachycardia—Prednisolone—psoriasis	0.000962	0.00158	CcSEcCtD
Vecuronium—Shock—Hydrocortisone—psoriasis	0.000947	0.00155	CcSEcCtD
Vecuronium—Nervous system disorder—Hydrocortisone—psoriasis	0.000944	0.00155	CcSEcCtD
Vecuronium—Tachycardia—Hydrocortisone—psoriasis	0.00094	0.00154	CcSEcCtD
Vecuronium—Flushing—Prednisone—psoriasis	0.000936	0.00154	CcSEcCtD
Vecuronium—Skin disorder—Hydrocortisone—psoriasis	0.000935	0.00154	CcSEcCtD
Vecuronium—Angioedema—Dexamethasone—psoriasis	0.000921	0.00151	CcSEcCtD
Vecuronium—Angioedema—Betamethasone—psoriasis	0.000921	0.00151	CcSEcCtD
Vecuronium—Angiopathy—Prednisone—psoriasis	0.000915	0.0015	CcSEcCtD
Vecuronium—Immune system disorder—Prednisone—psoriasis	0.000911	0.00149	CcSEcCtD
Vecuronium—Anaphylactic shock—Triamcinolone—psoriasis	0.000907	0.00149	CcSEcCtD
Vecuronium—Hypotension—Hydrocortisone—psoriasis	0.0009	0.00148	CcSEcCtD
Vecuronium—Shock—Triamcinolone—psoriasis	0.000892	0.00146	CcSEcCtD
Vecuronium—Tachycardia—Triamcinolone—psoriasis	0.000885	0.00145	CcSEcCtD
Vecuronium—Erythema—Prednisone—psoriasis	0.000878	0.00144	CcSEcCtD
Vecuronium—Urticaria—Cyclosporine—psoriasis	0.000861	0.00141	CcSEcCtD
Vecuronium—Rash—Mycophenolic acid—psoriasis	0.000844	0.00139	CcSEcCtD
Vecuronium—Dermatitis—Mycophenolic acid—psoriasis	0.000844	0.00138	CcSEcCtD
Vecuronium—Urticaria—Mycophenolate mofetil—psoriasis	0.00084	0.00138	CcSEcCtD
Vecuronium—Anaphylactic shock—Betamethasone—psoriasis	0.000823	0.00135	CcSEcCtD
Vecuronium—Anaphylactic shock—Dexamethasone—psoriasis	0.000823	0.00135	CcSEcCtD
Vecuronium—Shock—Betamethasone—psoriasis	0.000809	0.00133	CcSEcCtD
Vecuronium—Shock—Dexamethasone—psoriasis	0.000809	0.00133	CcSEcCtD
Vecuronium—Nervous system disorder—Dexamethasone—psoriasis	0.000807	0.00132	CcSEcCtD
Vecuronium—Nervous system disorder—Betamethasone—psoriasis	0.000807	0.00132	CcSEcCtD
Vecuronium—Tachycardia—Dexamethasone—psoriasis	0.000803	0.00132	CcSEcCtD
Vecuronium—Tachycardia—Betamethasone—psoriasis	0.000803	0.00132	CcSEcCtD
Vecuronium—Angioedema—Prednisone—psoriasis	0.000802	0.00132	CcSEcCtD
Vecuronium—Hypersensitivity—Cyclosporine—psoriasis	0.000798	0.00131	CcSEcCtD
Vecuronium—Urticaria—Prednisolone—psoriasis	0.000783	0.00129	CcSEcCtD
Vecuronium—Cardiac disorder—Methotrexate—psoriasis	0.000782	0.00128	CcSEcCtD
Vecuronium—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000779	0.00128	CcSEcCtD
Vecuronium—Hypotension—Betamethasone—psoriasis	0.000769	0.00126	CcSEcCtD
Vecuronium—Hypotension—Dexamethasone—psoriasis	0.000769	0.00126	CcSEcCtD
Vecuronium—Urticaria—Hydrocortisone—psoriasis	0.000765	0.00126	CcSEcCtD
Vecuronium—Angiopathy—Methotrexate—psoriasis	0.000765	0.00125	CcSEcCtD
Vecuronium—Immune system disorder—Methotrexate—psoriasis	0.000761	0.00125	CcSEcCtD
Vecuronium—Mediastinal disorder—Methotrexate—psoriasis	0.000759	0.00125	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	0.000742	0.00122	CcSEcCtD
Vecuronium—Erythema—Methotrexate—psoriasis	0.000734	0.0012	CcSEcCtD
Vecuronium—Hypersensitivity—Prednisolone—psoriasis	0.000726	0.00119	CcSEcCtD
Vecuronium—Urticaria—Triamcinolone—psoriasis	0.00072	0.00118	CcSEcCtD
Vecuronium—Anaphylactic shock—Prednisone—psoriasis	0.000716	0.00118	CcSEcCtD
Vecuronium—Hypersensitivity—Hydrocortisone—psoriasis	0.000709	0.00116	CcSEcCtD
Vecuronium—Shock—Prednisone—psoriasis	0.000705	0.00116	CcSEcCtD
Vecuronium—Nervous system disorder—Prednisone—psoriasis	0.000703	0.00115	CcSEcCtD
Vecuronium—Tachycardia—Prednisone—psoriasis	0.000699	0.00115	CcSEcCtD
Vecuronium—Skin disorder—Prednisone—psoriasis	0.000696	0.00114	CcSEcCtD
Vecuronium—Rash—Cyclosporine—psoriasis	0.000683	0.00112	CcSEcCtD
Vecuronium—Dermatitis—Cyclosporine—psoriasis	0.000682	0.00112	CcSEcCtD
Vecuronium—Hypersensitivity—Triamcinolone—psoriasis	0.000668	0.0011	CcSEcCtD
Vecuronium—Rash—Mycophenolate mofetil—psoriasis	0.000666	0.00109	CcSEcCtD
Vecuronium—Dermatitis—Mycophenolate mofetil—psoriasis	0.000666	0.00109	CcSEcCtD
Vecuronium—Urticaria—Dexamethasone—psoriasis	0.000653	0.00107	CcSEcCtD
Vecuronium—Urticaria—Betamethasone—psoriasis	0.000653	0.00107	CcSEcCtD
Vecuronium—Rash—Prednisolone—psoriasis	0.000622	0.00102	CcSEcCtD
Vecuronium—Dermatitis—Prednisolone—psoriasis	0.000621	0.00102	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	0.00062	0.00102	CcSEcCtD
Vecuronium—Rash—Hydrocortisone—psoriasis	0.000607	0.000996	CcSEcCtD
Vecuronium—Dermatitis—Hydrocortisone—psoriasis	0.000607	0.000996	CcSEcCtD
Vecuronium—Anaphylactic shock—Methotrexate—psoriasis	0.000599	0.000983	CcSEcCtD
Vecuronium—Nervous system disorder—Methotrexate—psoriasis	0.000587	0.000964	CcSEcCtD
Vecuronium—Skin disorder—Methotrexate—psoriasis	0.000582	0.000955	CcSEcCtD
Vecuronium—Rash—Triamcinolone—psoriasis	0.000572	0.000938	CcSEcCtD
Vecuronium—Dermatitis—Triamcinolone—psoriasis	0.000571	0.000937	CcSEcCtD
Vecuronium—Urticaria—Prednisone—psoriasis	0.000569	0.000934	CcSEcCtD
Vecuronium—Hypotension—Methotrexate—psoriasis	0.000559	0.000918	CcSEcCtD
Vecuronium—Hypersensitivity—Prednisone—psoriasis	0.000528	0.000866	CcSEcCtD
Vecuronium—Rash—Dexamethasone—psoriasis	0.000519	0.000851	CcSEcCtD
Vecuronium—Rash—Betamethasone—psoriasis	0.000519	0.000851	CcSEcCtD
Vecuronium—Dermatitis—Betamethasone—psoriasis	0.000518	0.000851	CcSEcCtD
Vecuronium—Dermatitis—Dexamethasone—psoriasis	0.000518	0.000851	CcSEcCtD
Vecuronium—Urticaria—Methotrexate—psoriasis	0.000476	0.000781	CcSEcCtD
Vecuronium—Rash—Prednisone—psoriasis	0.000452	0.000741	CcSEcCtD
Vecuronium—Dermatitis—Prednisone—psoriasis	0.000451	0.000741	CcSEcCtD
Vecuronium—Hypersensitivity—Methotrexate—psoriasis	0.000441	0.000724	CcSEcCtD
Vecuronium—Rash—Methotrexate—psoriasis	0.000377	0.00062	CcSEcCtD
Vecuronium—Dermatitis—Methotrexate—psoriasis	0.000377	0.000619	CcSEcCtD
